About docetaxrl anhydrous
Taxane chemotherapy medicine
Used for
- Breast cancer
- Non-small-cell lung cancer
- Prostate cancer
- Stomach and head and neck cancers
Usual adult dose
Usually 60–100 mg/m² by intravenous infusion every three weeks, depending on cancer and treatment combination.
Common side effects
- Low blood cell counts and infection
- Hair loss
- Nausea, vomiting, or diarrhoea
- Fluid retention and nerve pain or numbness
Important warnings
- Given by specialist teams; doses vary by cancer and blood test results.
- Can cause serious infections, severe allergic reactions, and liver problems.
- Steroid premedication is commonly used to reduce allergic reactions and fluid retention.
- Avoid live vaccines during treatment; report fever promptly.
Pregnancy
Can harm an unborn baby. Pregnancy should be avoided during treatment and for the period specified by the treating team afterward.
Breastfeeding
Breastfeeding is not recommended during treatment.
Interactions
- Strong CYP3A4 inhibitors, including some antifungals and antibiotics, may increase docetaxel exposure.
- Strong CYP3A4 inducers, including rifampicin and some seizure medicines, may reduce exposure.
- Other chemotherapy or medicines affecting blood counts can increase toxicity.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.